Clinical Trial Detail

NCT ID NCT02303990
Title RADVAX A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

breast cancer

Advanced Solid Tumor

lung non-small cell carcinoma

melanoma

pancreatic cancer

Therapies

Pembrolizumab

Age Groups: adult

No variant requirements are available.